Arent Fox Attorneys Teach Graduate Business Course on Legal Aspects of Biotech
The class is part of a curriculum on advanced topics in pharmacology, biologics, biodevices, clinical trials, biostatistics, and analytics, along with finance, marketing, intellectual property law, and new business development.
Guest lecturers for the course include Arent Fox attorneys Karen Ellis Carr, Alexander H. Spiegler, and Stephanie Trunk, as well as Rose and Associates, LLC Founder and President Lucy Rose, VP Regulatory Affairs and Quality Assurance for Aquestive Therapeutics Rikin Mehta, Mount Sinai IRB Chair for the Program for the Protection of Human Subjects Ilene Wilets, and AgTech Accelerator Director of IP, Regulatory & Product Development Megan Lyman.
Dr. Rana Khan, founding director of the Biotechnology Management and Entrepreneurship Program at the Katz School, said, “This program fills a critical need in the biotechnology education arena to prepare high-value professionals and entrepreneurs. What sets it apart is an interdisciplinary curriculum that weaves in science with business and management and a project-based focus to develop entrepreneurial thinkers who can successfully navigate the complex process of commercializing new products and remedies.”
Arent Fox’s Life Sciences group understands the challenge of a crowded market and the underlying technologies and confidentiality issues surrounding life sciences products and research. We help our clients manage the entire product life cycle, from scientific breakthrough through product development and production, to financing and global marketing and distribution.
Nathan Carlile, Head of Firmwide Communications
- Related Industries
- Related Practices